New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
07:19 EDTNDSNNordson poised for strong growth, says Oppenheimer
Oppenheimer expects Nordson's earnings power to increase and its organic growth to accelerate significantly as its investments bear fruit. The firm also expects the company to benefit from favorable customer spending trends, and it keeps an $85 price target and Outperform rating on the shares.
News For NDSN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 4, 2015
09:01 EDTNDSNNordson acquires MatriX Technologies
Subscribe for More Information
August 26, 2015
16:01 EDTNDSNNordson authorizes additional $200M repurchase plan
Subscribe for More Information
August 24, 2015
08:09 EDTNDSNNordson has reached compelling entry point, says Oppenheimer
After Nordson's stock dropped 12% in the wake of the company's earnings, Oppenheimer believes that the stock's valuation is "compelling." The firm thinks that the company's growth profile is "good for current times." It keeps a $75 price target and Outperform rating on the shares.
August 21, 2015
09:13 EDTNDSNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Accuray (ARAY), up 12.7%... Brocade (BRCD), up 6%... salesforce.com (CRM), up 3.5%. DOWN AFTER EARNINGS: Intuit (INTU), down 6.7%... Deere (DE), down 5.4%... Nordson (NDSN), down 4.4%. ALSO LOWER: GigOptix (GIG), down 20% after 9.22M share Spot Secondary priced at $1.70... VirnetX Holding (VHC), down 19.8% after filing to sell 35M shares of common stock... Northwest Biotherapeutics (NWBO), down 8.7% after TheStreet's Adam Feuerstein reports, via Twitter, that CVax Phase 3 study has been temporarily halted in Germany.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use